Head & Neck/Thyroid Cancers
Conference Coverage
Weekly cisplatin new standard in postop head and neck cancer
News from the FDA/CDC
Nivolumab approved to treat esophageal squamous cell carcinoma
From the Journals
Thyroid cancer overdiagnosis reaches beyond affluent regions
Trends of overscreening seen in affluent economies appear to be spreading to middle-income countries as scanning becomes available. “In short, it...
From the Journals
American Cancer Society update: ‘It is best not to drink alcohol’
Feature
Can an app guide cancer treatment decisions during the pandemic?
Feature
‘A good and peaceful death’: Cancer hospice during the pandemic
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
News
Oncologists’ income and satisfaction are up
From the Journals
World first: Saliva test detects occult HPV-driven oropharyngeal cancer
Conference Coverage
Video coaching may relieve anxiety and distress for long-distance cancer caregivers